HAIC combined with atezolizumab and bevacizumab versus lenvatinib in advanced hepatocellular carcinoma: a multicenter propensity score matching analysis
Purpose This study aimed to evaluate the clinical efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) combined with atezolizumab and bevacizumab (HTA) versus HAIC combined with lenvatinib (HL) in the treatment of advanced hepatocellular carcinoma (HCC). Methods A multicenter retrospective study was con...